Company Filing History:
1 out of 870 
1 out of 5,089 
1 out of 1 Years Active: 2021
Title: Marie Mura: Innovator in Infectious Disease Prevention
Introduction
Marie Mura is a prominent inventor based in Avrainville, France. She has made significant contributions to the field of infectious disease prevention, particularly through her innovative work on multivalent vaccines. Her research focuses on the use of measles virus defective interfering particles to enhance vaccine efficacy.
Latest Patents
Marie Mura holds a patent for "Compositions and methods comprising measles virus defective interfering particles for the prevention of infectious diseases." This invention is crucial in the field of prevention and treatment of infectious diseases. The patent details the characterization of 5' copy-back DI-RNAs produced by recombinant measles virus strains, including rMV-based vaccines and wild-type MV. The efficiency of these DI-RNAs in different cell types was compared, and for the first time, specific binding to RIG-I, MDA5, and LGP2 was assessed, linking it to functional outcomes in type-I IFN signaling. The composition includes a mixture of particles from a rescued recombinant MV-derived virus encoding at least one antigen and a recombinant and/or purified protein.
Career Highlights
Throughout her career, Marie Mura has worked with esteemed institutions such as Institut Pasteur and the Centre National de la Recherche Scientifique. Her research has significantly advanced the understanding of vaccine development and infectious disease prevention.
Collaborations
Marie has collaborated with notable colleagues, including Frederic Tangy and Anastassia Komarova, contributing to her innovative research and development efforts.
Conclusion
Marie Mura's work in the field of infectious disease prevention exemplifies the impact of innovative research on public health. Her contributions through patents and collaborations continue to pave the way for advancements in vaccine technology.